53.29
1.77%
-0.96
Immunocore Holdings plc ADR Aktie (IMCR) Neueste Nachrichten
Immunocore Holdings plc ADR [IMCR] Records 200-Day SMA of $59.21 – Knox Daily - Knox Daily
Knox Daily
Should investors be concerned about Immunocore Holdings plc ADR (IMCR)? – US Post News - US Post News
US Post News
Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know - Yahoo Canada Shine On
Yahoo Canada Shine On
The Potential Rise in the Price of Immunocore Holdings plc ADR (IMCR) following insiders activity – Knox Daily - Knox Daily
Knox Daily
Balance Sheet Breakdown: Immunocore Holdings plc ADR (IMCR)'s Debt-to-Equity and Long-Term Debt/Eq Ratios ... - The Dwinnex
The Dwinnex
Are Medical Stocks Lagging Immunocore (IMCR) This Year? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to Know - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Immunocore shares target trimmed by Mizuho despite Kimmtrak revenue beat - Investing.com UK
Investing.com UK
Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Are Medical Stocks Lagging Galapagos (GLPG) This Year? - Yahoo Singapore News
Yahoo Singapore News
A year in review: Immunocore Holdings plc ADR (IMCR)'s performance in the last year – US Post News - US Post News
US Post News
Analytical Overview: Immunocore Holdings plc ADR (IMCR)'s Ratios Tell a Financial Story – DWinneX - The Dwinnex
The Dwinnex
Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know - Yahoo Movies UK
Yahoo Movies UK
Immunocore reports first quarter financial results and provides a business update
GlobeNewswire Inc.
Where Immunocore Hldgs Stands With Analysts
Benzinga
Immunocore announces upcoming presentation and posters at ASCO 2024
GlobeNewswire Inc.
Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Benzinga
Immunocore to present at upcoming investor conferences
GlobeNewswire Inc.
Immunocore presented two posters at CROI 2024
GlobeNewswire Inc.
Key Takeaways From Immunocore Hldgs Analyst Ratings
Benzinga
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
GlobeNewswire Inc.
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
GlobeNewswire Inc.
Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up
Zacks Investment Research
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
Zacks Investment Research
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology - Yahoo Finance
Yahoo Finance
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
Zacks Investment Research
5 Biotech Stocks to Consider for Your Portfolio in 2024
Zacks Investment Research
Immunovant (IMVT) Up 3% as Q3 Earnings Top, Pipeline in Focus
Zacks Investment Research
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
Zacks Investment Research
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up
Zacks Investment Research
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up
Zacks Investment Research
Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat
Zacks Investment Research
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
Zacks Investment Research
Immunocore Prices Upsized Convertible Senior Notes Offering
GlobeNewswire Inc.
Immunocore Announces Proposed Convertible Senior Notes Offering
GlobeNewswire Inc.
Best Momentum Stocks to Buy for January 10th - MSN
MSN
New Strong Buy Stocks for January 10th
Zacks Investment Research
Best Momentum Stocks to Buy for January 10th - Zacks Investment Research
Zacks Investment Research
Immunocore's Pipeline Is Among The Strongest In Broader Biotech Universe: Analyst
Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
GlobeNewswire Inc.
Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research
How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32%
Zacks Investment Research
Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?
Zacks Investment Research
Bears are Losing Control Over Immunocore Holdings PLC Sponsored ADR (IMCR), Here's Why It's a 'Buy' Now
Zacks Investment Research
5 Analysts Have This to Say About Immunocore Hldgs
Benzinga
Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains? - Yahoo News UK
Yahoo News UK
Wall Street Analysts Believe Immunocore Holdings PLC Sponsored ADR (IMCR) Could Rally 60%: Here's is How to ... - Yahoo Finance
Yahoo Finance
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia ... - PR Newswire
PR Newswire
Kapitalisierung:
|
Volumen (24h):